Fulcrum Therapeutics logo

Fulcrum Therapeutics

FULC | NASDAQ
Chart Builder DCF Calculator
$3.71
-$0.06 (-1.59%)
At close: Nov 16, 2026, 4:00 PM ET
$3.72
+$0.01 (+0.27%)
After-hours: Nov 16, 2026, 5:58 PM ET
-1.59%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
24.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #941/1021 (Top 92%)

Key Statistics

Market Data

Market Cap $283.38M
1D Range
3.70 3.78
52W Range
3.14 14.60

Valuation (TTM)

PE -3.57
PB 0.94
EV/EBITDA 0.24

Valuation (NTM)

Forward PE N/A
Forward PEG 0.07
Price Target $4.00
Loading financial charts...

Profile

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical firm committed to developing life-improving treatments for patients in the United States afflicted by genetically defined diseases with...

Sector Healthcare
Industry Biotechnology
Employees 9
IPO Date Jul 18, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
9
Consensus
Hold
Price Target
$4.00
Upside
+7.82%
Buy (1)
Hold (5)
Sell (3)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.